Columnist Candace Semien plunges into the debate of whether to use disabled, differently abled, or another term to describe a ...

Among the many things columnist Candace Semien had to learn while living with lupus were the types and function of various ...

The trial, Reversing Autoimmunity through Cell Therapy (REACT-01), is targeted for a summer launch. Seattle Children’s Therapeutics, a nonprofit that’s been running immunotherapy trials for children, ...

This is the first time a blood biomarker has been linked to fatigue in SLE patients. The findings were recently presented at the 11 th European Lupus Meeting in Düsseldorf, Germany, in the study, “ ...

His soulful, smooth voice continues: “Yeah, let yourself go, follow that feeling/ Maybe something new is what you’re needing/ Like a real night, let your hair down, feel alive.” Doing something for ...

“We are delighted with the news of the preliminary results of the Phase III confirmatory study of our proprietary novel fusion protein Telitacicept for the treatment of SLE in China,” Jianmin Fang, ...

Bionews, Inc., is independently owned and operated. It does not produce, market, or sell any product intended to treat, manage, or diagnose lupus or any other condition. The focus of Bionews is to ...

SWEET POTATO AND BLACK BEAN SOUP 2 Tbsp olive oil 1 medium onion, diced 3 c. peeled and diced sweet potato 2 Tbsp chili powder 2 tsp. cumin 1/2 tsp. garlic powder 1 tsp. salt 4 c. chicken or vegetable ...

Brepocitinib designed to block action of TYK2 and JAK1 enzymes Brepocitinib is a first-in-class oral medication designed to block the action of two enzymes — TYK2 and JAK1 — that are involved in ...

The cells can be obtained from the umbilical cord, bone marrow, adipose tissue, muscle, and the lungs. Researchers at the Medical University of South Carolina (MUSC) conducted a Phase 1 clinical trial ...

The study, “ VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease,” was published in the journal Science. Mitochondria are the small compartments in cells ...

The Phase 1 study will enroll people with moderate to severe SLE who’ve failed to respond to at least two standard immunosuppressive medications. Century expects the trial will start in the first half ...